Bacterial Vaccines Research & Early Development ▲ Sign in to save

• ▲ Jeroen Geurtsen

  Sanofi (Netherlands) · Janssen (Netherlands) Biochemistry, Genetics and Molecular Biology
  3.61k

  citations

  25

  h-index

  42

  Aachen papers

1 result

• Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis

  2023 Clinical Microbiology and Infection review Immunology and Microbiology Antibiotic Use and Resistance Open access

  23

  citations
• Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies

  2024 Eurosurveillance article Immunology and Microbiology Antibiotic Use and Resistance Open access

  7

  citations
• Impact of Invasive Escherichia Coli Disease on Clinical Outcomes and Medical Resource Utilization Among Asian Patients in the United States

  2024 Infectious Diseases and Therapy article Medicine Sepsis Diagnosis and Treatment Open access

  1

  citations

3 results